Related Experiment Video
Updated: Aug 15, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Chemokines: integrators of pain and inflammation
Fletcher A White1, Sonia K Bhangoo, Richard J Miller
1Department of Cell Biology, Neurobiology and Anatomy, Stritch School of Medicine, Loyola University, Maywood, Illinois 60153, USA.
Abstract:
Chronic (neuropathic) pain is one of the most widespread and intractable of human complaints, as well as being one of the most difficult syndromes to treat successfully with drugs or surgery. The development of new therapeutic approaches to the treatment of painful neuropathies requires a better understanding of the mechanisms that underlie the development of these chronic pain syndromes. It is clear that inflammatory responses often accompany the development of neuropathic pain, and here we discuss the idea that chemokines might be key to integrating the development of pain and inflammation and could furnish new leads in the search for effective analgesic agents for the treatment of painful neuropathies.
Related Concept Videos
Nociception
Acute Inflammation III: Local and Systemic Effects
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Inflammation
Analgesia and Pain Management
